COCP Return on Tangible Equity | COCRYSTAL PHARMA, INC.

COCRYSTAL PHARMA, INC. (COCP) Return on Tangible Equity

2026-06-30: Return Tang Equity 54.61%.
2026-03-31: Return Tang Equity 58.38%.
2025-12-31: Return Tang Equity 68.41%.
2025-09-30: Return Tang Equity 83.58%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	54.61%
2026-03-31	58.38%
2025-12-31	68.41%
2025-09-30	83.58%
2025-06-30	90.32%
2025-03-31	132.78%
2024-12-31	180.13%
2024-09-30	286.07%
2024-06-30	968.83%
2024-03-31	-500.85%
2023-12-31	-251.75%
2023-09-30	-157.40%
2023-06-30	-126.65%
2023-03-31	-258.08%
2022-12-31	-190.78%
2022-09-30	-123.97%
2022-06-30	-120.26%
2022-03-31	-28.81%
2021-12-31	-24.33%
2021-09-30	-19.42%
2021-06-30	-16.37%
2021-03-31	-31.68%
2020-12-31	-29.00%
2020-09-30	-181.02%
2020-06-30	-309.35%
2020-03-31	-250.73%
2019-12-31	-744.78%
2019-09-30	-825.88%
2019-06-30	-631.82%
2019-03-31	-525.29%
2018-12-31	-3175.61%
2018-09-30	0.95%
2018-06-30	0.09%
2018-03-31	-2.25%
2017-12-31	-4.67%
2017-09-30	-210.14%
2017-06-30	-197.43%
2017-03-31	-211.93%
2016-12-31	-202.50%
2016-09-30	-38.61%
2016-06-30	-37.64%
2016-03-31	-36.15%
2015-12-31	-49.02%
2015-09-30	-16.42%
2015-06-30	-18.01%
2015-03-31	-13.19%
2014-12-31	0.17%
2014-09-30	36.22%
2014-06-30	52.43%
2014-03-31	98.51%
2013-12-31	38.84%
2013-09-30	56.74%
2013-06-30	87.82%
2013-03-31	85.89%
2012-12-31	127.93%
2012-09-30	482.44%
2012-03-31	113.94%
2011-12-31	125.49%
2011-09-30	194.06%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	68.18%
2024-12-31	179.35%
2023-12-31	-253.26%
2022-12-31	-191.18%
2021-12-31	-24.35%
2020-12-31	-29.04%
2019-12-31	-749.70%
2018-12-31	-3265.28%
2017-12-31	-1.53%
2016-12-31	-202.73%
2015-12-31	-49.04%
2014-12-31	0.17%
2013-12-31	38.67%
2012-12-31	127.93%
2011-12-31	134.96%
2010-12-31	54.28%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ATOSSA THERAPEUTICS, INC. (ATOS)	United States	$0.021B	-0.52
ARTELO BIOSCIENCES, INC. (ARTL)	United States	$0.023B
Neuphoria Therapeutics Inc. (NEUP)	United States	$0.020B	-1.77
Marker Therapeutics, Inc. (MRKR)	United States	$0.020B	-2.86
Cellectar Biosciences, Inc. (CLRB)	United States	$0.020B	-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)	United States	$0.019B	-0.31
TherapeuticsMD, Inc. (TXMD)	United States	$0.024B	-117.87
NextCure, Inc. (NXTC)	United States	$0.024B	-0.15
Rocket One Inc. (RKTO)	United States	$0.019B
AYTU BIOPHARMA, INC (AYTU)	United States	$0.025B	-1.62